ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0478

Skin Sodium in Patients with Rheumatoid Arthritis: Association with Blood Pressure and Disease Activity

Carolina Ramirez, Annette Oeser, Rachelle Crescenzi, C. Michael Stein and Michelle Ormseth, Vanderbilt University Medical Center, Nashville, TN

Meeting: ACR Convergence 2024

Keywords: Biomarkers, Cardiovascular, Imaging, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Sodium is stored in tissues such as the skin where it may contribute to development and progression of autoimmune diseases and hypertension through activation of local immune cells. There is little information about tissue sodium in patients with rheumatoid arthritis (RA). The purpose of this study was to determine if skin sodium content is: 1) higher in participants with RA than in controls, and 2) associated with blood pressure and disease activity in patients with RA.

Methods: This cross-sectional study included 32 patients with RA and 33 control participants. Lower leg skin sodium content was measured using magnetic resonance imaging. Office and ambulatory 24-hour blood pressure measurements were obtained, and disease activity was assessed by Disease Activity Score-28 for RA with CRP (DAS28-CRP).

Results: Participant demographics are included in Table. Skin sodium content was higher in patients with RA than in control participants (14.22 [12.82, 18.04] vs 12.41 [10.67, 14.55] mmol/L), p=0.005 (Figure 1). Every 1 mmol/l increase in skin sodium was associated with a 1.05 mmHg (95% CI 0.29, 1.82 mmHg) increase in average 24-hour systolic blood pressure (p=0.009) and remained significant after adjustment for age (p adj = 0.04) (Figure 2); similarly every 1 mmol/l increase in skin sodium was associated with 1.17 mmHg (0.42, 1.92 mmHg) increase in average diurnal systolic blood pressure (p=0.003) and remained significant after adjustment for age (p= 0.02). In contrast, there was no significant correlation between skin sodium and nocturnal blood pressure, DAS28 score or its components.

Conclusion: Skin sodium is increased in patients with RA compared to control participants and is correlated with 24-hour and diurnal systolic blood pressure but not RA disease activity. Future studies testing the impact of dietary salt on blood pressure and disease activity will help elucidate these relationships.

Supporting image 1

Table 1. Demographics of RA and control participants

Supporting image 2

Figure 1. Skin sodium measured by MRI was significantly elevated in RA (N=32) versus control participants (N=33). Box plots represent median, 25th and 75th percentiles and whiskers represent the 5th and 95th percentiles. Mann Whitney U, P=0.005.

Supporting image 3

Figure 2. Average 24-hour systolic blood pressure was correlated significantly with skin sodium (P=0.009).


Disclosures: C. Ramirez: None; A. Oeser: None; R. Crescenzi: None; C. Stein: None; M. Ormseth: None.

To cite this abstract in AMA style:

Ramirez C, Oeser A, Crescenzi R, Stein C, Ormseth M. Skin Sodium in Patients with Rheumatoid Arthritis: Association with Blood Pressure and Disease Activity [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/skin-sodium-in-patients-with-rheumatoid-arthritis-association-with-blood-pressure-and-disease-activity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/skin-sodium-in-patients-with-rheumatoid-arthritis-association-with-blood-pressure-and-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology